Group 1 - The core point of the news is that Purui Eye Hospital Group's stock price increased by 5.07% to 38.77 CNY per share, with a total market capitalization of 5.801 billion CNY as of the report date [1] - Purui Eye Hospital, established on March 23, 2006, and listed on July 5, 2022, provides comprehensive ophthalmic medical services, including diagnosis, treatment, and optical services [1] - The revenue composition of Purui Eye Hospital includes: refractive projects 49.36%, cataract projects 19.77%, comprehensive eye disease projects 16.65%, optical projects 13.03%, and other services 1.18% [1] Group 2 - From the perspective of major shareholders, Rongtong Fund's health industry flexible allocation mixed fund A/B (000727) reduced its holdings by 192,500 shares in the third quarter, now holding 2.4 million shares, accounting for 1.69% of the circulating shares [2] - The fund has achieved a return of 13.2% year-to-date, ranking 5439 out of 8219 in its category, and a return of 2.01% over the past year, ranking 7380 out of 8125 [2] - The fund manager, Wan Minyuan, has a tenure of 9 years and 79 days, with the fund's total asset size at 5.957 billion CNY and a best return of 139.91% during his tenure [3] Group 3 - The Rongtong health industry flexible allocation mixed fund A/B (000727) has Purui Eye Hospital as its eighth largest holding, with the stock accounting for 3.62% of the fund's net value [4] - The fund's floating profit from its holdings in Purui Eye Hospital is approximately 4.488 million CNY as of the report date [4]

Core Viewpoint - On August 29, 2023, Puri Eye Hospital's stock fell by 4.63%, with a trading volume of 203 million yuan, indicating a negative market sentiment towards the company [1]. Financing and Trading Data - On August 29, Puri Eye Hospital had a financing buy amount of 18.65 million yuan and a financing repayment of 24.84 million yuan, resulting in a net financing outflow of 6.19 million yuan [1]. - As of August 29, the total margin trading balance for Puri Eye Hospital was 88.40 million yuan, with the financing balance at 87.88 million yuan, accounting for 1.44% of the circulating market value, which is below the 10th percentile level over the past year [1]. - The company had no shares repaid in the securities lending market on August 29, with 200 shares sold, amounting to 8,156 yuan at the closing price [1]. Company Overview - Puri Eye Hospital Group Co., Ltd. was established on March 23, 2006, and listed on July 5, 2022. The company provides comprehensive medical services for eye diseases, including diagnosis, treatment, and optical services [1]. - The revenue composition of the company includes refractive projects (49.36%), cataract projects (19.77%), comprehensive eye disease projects (16.65%), optical projects (13.03%), and other services (1.18%) [1]. Financial Performance - For the first half of 2025, Puri Eye Hospital reported a revenue of 1.459 billion yuan, representing a year-on-year growth of 2.74%. However, the net profit attributable to shareholders decreased by 66.12% to 14.67 million yuan [2]. - Since its A-share listing, the company has distributed a total of 74.51 million yuan in dividends [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Puri Eye Hospital increased by 6.24% to 10,600, while the average circulating shares per person decreased by 5.87% to 6,647 shares [2]. - Among the top ten circulating shareholders, notable changes include an increase in holdings by Rongtong Health Industry Flexible Allocation Mixed A/B and the entry of Yuanxin Yongfeng Ju You A as a new shareholder [3].